These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 10786664

  • 1. Sulindac and exisulind exhibit a significant antiproliferative effect and induce apoptosis in human hepatocellular carcinoma cell lines.
    Rahman MA, Dhar DK, Masunaga R, Yamanoi A, Kohno H, Nagasue N.
    Cancer Res; 2000 Apr 15; 60(8):2085-9. PubMed ID: 10786664
    [Abstract] [Full Text] [Related]

  • 2. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S, Urade M, Nishimura N, Maeda T, Takaoka K, Noguchi K, Sakurai K.
    Int J Oncol; 2003 Sep 15; 23(3):665-72. PubMed ID: 12888902
    [Abstract] [Full Text] [Related]

  • 3. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.
    Molina MA, Sitja-Arnau M, Lemoine MG, Frazier ML, Sinicrope FA.
    Cancer Res; 1999 Sep 01; 59(17):4356-62. PubMed ID: 10485483
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Induction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors.
    Foderà D, D'Alessandro N, Cusimano A, Poma P, Notarbartolo M, Lampiasi N, Montalto G, Cervello M.
    Ann N Y Acad Sci; 2004 Dec 01; 1028():440-9. PubMed ID: 15650269
    [Abstract] [Full Text] [Related]

  • 6. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
    Bae SH, Jung ES, Park YM, Kim BS, Kim BK, Kim DG, Ryu WS.
    Clin Cancer Res; 2001 May 01; 7(5):1410-8. PubMed ID: 11350912
    [Abstract] [Full Text] [Related]

  • 7. Antiproliferative effects of nitrosulindac on human colon adenocarcinoma cell lines.
    Lavagna C, Burgaud JL, Del Soldato P, Rampal P.
    Biochem Biophys Res Commun; 2001 Jun 15; 284(3):808-16. PubMed ID: 11396974
    [Abstract] [Full Text] [Related]

  • 8. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Cheng AS, Chan HL, Leung WK, Wong N, Johnson PJ, Sung JJ.
    Int J Oncol; 2003 Jul 15; 23(1):113-9. PubMed ID: 12792783
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines.
    Cheng J, Imanishi H, Amuro Y, Hada T.
    Int J Cancer; 2002 Jun 10; 99(5):755-61. PubMed ID: 12115513
    [Abstract] [Full Text] [Related]

  • 12. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
    Yoshizawa K, Cioca DP, Kawa S, Tanaka E, Kiyosawa K.
    Cancer; 2002 Nov 15; 95(10):2243-51. PubMed ID: 12412180
    [Abstract] [Full Text] [Related]

  • 13. Antitumor effect of vesnarinone on human hepatocellular carcinoma cell lines.
    Kubo K, Matsuzaki Y, Kato A, Terai S, Okita K.
    Int J Oncol; 1999 Jan 15; 14(1):41-6. PubMed ID: 9863007
    [Abstract] [Full Text] [Related]

  • 14. Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines.
    Lim JT, Piazza GA, Han EK, Delohery TM, Li H, Finn TS, Buttyan R, Yamamoto H, Sperl GJ, Brendel K, Gross PH, Pamukcu R, Weinstein IB.
    Biochem Pharmacol; 1999 Oct 01; 58(7):1097-107. PubMed ID: 10484067
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sulindac and its derivatives: a novel class of anticancer agents.
    Haanen C.
    Curr Opin Investig Drugs; 2001 May 01; 2(5):677-83. PubMed ID: 11569947
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The nonsteroidal anti-inflammatory drug sulindac causes down-regulation of signal transducer and activator of transcription 3 in human oral squamous cell carcinoma cells.
    Nikitakis NG, Hamburger AW, Sauk JJ.
    Cancer Res; 2002 Feb 15; 62(4):1004-7. PubMed ID: 11861373
    [Abstract] [Full Text] [Related]

  • 19. Benzylamide sulindac analogues induce changes in cell shape, loss of microtubules and G(2)-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells.
    Moon EY, Lerner A.
    Cancer Res; 2002 Oct 15; 62(20):5711-9. PubMed ID: 12384529
    [Abstract] [Full Text] [Related]

  • 20. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
    Ding XZ, Tong WG, Adrian TE.
    Anticancer Res; 2000 Oct 15; 20(4):2625-31. PubMed ID: 10953335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.